Cell death-related molecules and biomarkers for renal cell carcinoma targeted therapy

Renal cell carcinoma (RCC) is not sensitive to conventional radio- and chemotherapies and is at least partially resistant to impairments in cell death-related signaling pathways. The hallmarks of RCC formation include diverse signaling pathways, such as maintenance of proliferation, cell death resis...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Yongchang, Zeng, Tao, Liang, Xiongfa, Wu, Weizou, Zhong, Fangling, Wu, Wenqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708252/
https://www.ncbi.nlm.nih.gov/pubmed/31462894
http://dx.doi.org/10.1186/s12935-019-0939-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708252/
https://www.ncbi.nlm.nih.gov/pubmed/31462894
http://dx.doi.org/10.1186/s12935-019-0939-2

Ejemplares similares